Suchergebnisse - "Rimassa, Lorenza"

PubPharm (54)

1

Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

enthalten in: Hepatology international | 2023

von Vithayathil, M. | D’Alessio, A. | Fulgenzi, C. | +32

2

Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study

enthalten in: Journal of cancer research and clinical oncology | 2022

von Persano, M. | Rimini, M. | Tada, T. | +77

3

Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis

enthalten in: Targeted oncology | 2022

von Rimini, M. | Burgio, V. | Antonuzzo, L. | +13

4

Correction to: Efficacy and Safety Results from a Phase 2, Randomized, Double Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular Carcinoma

enthalten in: Clinical drug investigation | 2022

von Ryoo, B. | Palmer, D. | Park, S. | +6

5

Efficacy and Safety Results from a Phase 2, Randomized, Double-Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular Carcinoma

enthalten in: Clinical drug investigation | 2021

von Ryoo, B. | Palmer, D. | Park, S. | +5

6

Systemic Treatment for Older Patients with Unresectable Hepatocellular Carcinoma

enthalten in: Drugs & aging | 2021

von Cammarota, A. | D’Alessio, A. | Pressiani, T. | +2

7

Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis

enthalten in: Journal of cancer research and clinical oncology | 2021

von Casadei-Gardini, A. | Rimassa, L. | Rimini, M. | +15

8

Extensive molecular reclassification: new perspectives in small bowel adenocarcinoma?

enthalten in: Medical oncology | 2021

von Casadei-Gardini, A. | Lonardi, S. | Smiroldo, V. | +11

9

Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study

enthalten in: Supportive care in cancer | 2021

von Raimondi, A. | Corallo, S. | Lonardi, S. | +25

10

Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity

enthalten in: Journal of cancer research and clinical oncology | 2020

von Franzese, C. | Bonu, M. | Comito, T. | +7

1
2
3
4
5
6
Nächster »
[6]